Arkopharma Laboratorios has presented this Wednesday, the session ‘Overweight in times of pandemic’, ‘Figurmed Metabol’, which includes the first naturally occurring compound.
This pharmaceutical preparation contains the active ‘Metabolaid’, a which has been the subject of a European Union research project within the Horizon 2020 funds that has allowed to demonstrate its scientific evidence and whose authors have described this compound as the first to demonstrate various benefits for weight control.
So, has six clinical studies in more than 500 patients that demonstrate its usefulness in this sense and for the reduction of Figurmed Metabol’ is the new bet of Arkopharma Laboratories for weight control from the pharmacy with one hundred percent natural products.
“This new preparation contains an innovative patented complex, ‘Metabolaid’, which is especially indicated for those people who are overweight and have symptoms associated with metabolic syndrome and who above all need to lose fat mass”, said the pharmacist from the medical department of the company, Victoria Lara.
Lemon verbena has shown its benefits to inhibit the production of fat, reduce blood sugar, fat burning effect, reduction of obesity. For its part, hibiscus induces satiety and has antioxidant and anti-inflammatory effects.
In fact, a recent Spanish study published in the magazine ‘Foods’ concludes that the body mass index and fat mass, especially in the abdominal area.
‘Metabolaid’, which is made up of extracts of hibiscus and lemon verbena, has been analyzed in a European Union research project with Horizon 2020 funds and has led to the conclusion that it is a metabolic regulator “which can inhibit fat accumulation in adipose tissue and the liver.”
One of the clinical studies carried out reveals that those people who take this compound while following a controlled diet lose twice as much weight as those who only follow a diet. Specific, Reduce up to two kilograms of body fat around the abdominal perimeter and arm contour.
In addition, parameters such as blood pressure, blood glucose, triglycerides and blood glucose levels decreased significantly in patients who had used ‘Metabolaid’ for two months. According to the authors of this project, called ‘Innoprefat’, there are many compounds that can help lose weight, regulate cholesterol or control glucose metabolism, but ‘Metabolaid’ is the first to do it all and, with a total of five clinical studies already published and another in the process of being published so far, it is also the one that provides the most scientific evidence.